TABLE 2.
Postintervention fasting plasma biochemistry adjusted for baseline variables1
| Treatment | |||
|---|---|---|---|
| Variable | Resveratrol (n = 20) | Placebo (n = 21) | P value |
| Glucose, mmol/L | 5.2 ± 0.07 | 5.2 ± 0.06 | 0.945 |
| Insulin, μU/mL | 8.6 ± 0.42 | 8.3 ± 0.40 | 0.671 |
| HbA1c, mmol/mol | 35.8 ± 0.43 | 37.6 ± 0.44 | 0.007 |
| Triglycerides, mmol/L | 1.6 ± 0.10 | 1.7 ± 0.10 | 0.468 |
| Free fatty acids, µmol/L2 | 531 ± 30 | 510 ± 29 | 0.625 |
| Total cholesterol, mmol/L | 5.4 ± 0.13 | 5.5 ± 0.12 | 0.696 |
| HDL cholesterol, mmol/L | 1.4 ± 0.04 | 1.5 ± 0.04 | 0.462 |
| LDL cholesterol, mmol/L | 3.3 ± 0.11 | 3.3 ± 0.10 | 0.778 |
| Bilirubin, µmol/L | 11 ± 0.7 | 11 ± 0.7 | 0.487 |
| Creatinine, µmol/L3 | 81 ± 2.4 | 84 ± 2.4 | 0.249 |
| Urea, mmol/L4 | 5.2 ± 0.20 | 5.3 ± 0.20 | 0.511 |
| AST, U/L | 24 ± 1.2 | 23 ± 1.1 | 0.441 |
| ALT, U/L | 26 ± 1.5 | 25 ± 1.5 | 0.536 |
1
Postintervention data are presented as adjusted means ± SEs. Postintervention variables were compared using 1-way ANCOVA, implementing the corresponding baseline variables as covariates. ALT, alanine transaminase; AST, aspartate transaminase; HbA1c, glycated hemoglobin.
2
Data from 1 participant were missing in the resveratrol arm.
3
Data from 1 participant were missing in the placebo arm.
4
Data from 2 participants were missing in the resveratrol arm.